Top compounds associated with response to FSHR


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.034 0.3
mRNA SN-38 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA XL765 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.055 0.3
Download CSV